Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2009
12/29/2009US7638638 Antiinflamamtory agents; autoimmune disease; immunosuppressants;multiple sclerosis; antiarthritic agents
12/29/2009US7638495 inhibiting precipitation; bone morphogenic proteins
12/29/2009CA2429440C Dehalogeno-compounds
12/29/2009CA2339054C E-isomeric fullerene derivatives
12/29/2009CA2282720C Dolastatin-15 derivatives in combination with taxanes
12/24/2009US20090318667 Peptoid compositions and methods of using the same
12/24/2009US20090318368 Angiotensin-converting enzyme inhibitory peptides
12/24/2009US20090318367 Use of SH2 STAT3/STAT1 Peptidomimetics as Anticancer Drugs
12/24/2009US20090318366 Cholesterol lowering protein hydrolysates
12/24/2009US20090317409 Antibodies for ubiquitinated proteins
12/23/2009WO2009154169A1 Peptide derivative and composition for promoting tear secretion comprising the same
12/23/2009WO2009153180A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009EP1613302B1 Preserved and stable compositions containing peptide copper complexes and methods related thereto
12/23/2009CN101611050A Pharmaceutically acceptable salts of Thymodepressin and processes for their manufacture
12/23/2009CN101611039A HCV NS3 protease inhibitors
12/23/2009CN101608203A Fish skin collagen peptide with moistening effect and preparation process and application thereof
12/23/2009CN101607982A Fish skin collagen peptide with whitening effect and preparation process and application thereof
12/23/2009CA2726703A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009CA2726161A1 A peptide derivative and a composition for promoting lacrimal secretion comprising the same
12/22/2009US7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds
12/22/2009US7635694 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
12/22/2009CA2502269C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/22/2009CA2487306C Novel piperidine compound
12/22/2009CA2276267C Peptide-lipid conjugates, liposomes and liposomal drug delivery
12/17/2009WO2009151708A2 Peptide analogs of alpha-melanocyte stimulating hormone
12/17/2009WO2009151520A2 Biocompatible and biodegradable elastomeric polymers
12/17/2009WO2009149880A1 Lactobacillus helveticus strains for producing hypotensive peptides
12/17/2009WO2009117539A3 Bioluminescent construct
12/17/2009US20090312540 Spatially-defined macrocycles incorporating peptide bond surrogates
12/17/2009US20090312270 Peptides having an ace inhibiting effect
12/17/2009US20090312265 Novel antimicrobial peptides and use thereof
12/17/2009US20090312241 Macrocyclic Compounds as Antiviral Agents
12/17/2009US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
12/17/2009US20090311177 Radiolabelling Methods
12/17/2009CA2726076A1 Peptide analogs of alpha-melanocyte stimulating hormone
12/17/2009CA2725611A1 Lactobacillus helveticus strains for producing hypotensive peptides
12/17/2009CA2723824A1 Biocompatible and biodegradable elastomeric polymers
12/16/2009EP2132220A1 Integrin targeted cyclopeptide ligands, their preparation and use
12/16/2009EP2132219A2 Ace-inhibitory peptides from whey and methods for providing the same.
12/16/2009CN101605806A Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan
12/16/2009CN101602792A Novel antibacterial lipopeptid and preparation and application thereof
12/16/2009CN101602791A Integrin receptor target lipidosome drug carrier, preparation method and application thereof
12/16/2009CN100569796C Immune modulating peptide
12/15/2009US7632933 Corticotropin releasing factor 2 receptor agonists
12/15/2009US7632919 Polystyrene binding peptides and methods of use
12/15/2009US7632855 5-(5-Chloro-2,4-dihydroxy-phenyl)-4-(4-methoxy-phenyl)-2H-pyrazole-3-carboxylic acid, for example; for treatment of diseases which are mediated by excessive or inappropriate HSP90 activity, such as cancers
12/15/2009US7632805 Administering a biodrug comprising a growth factor binding compounds having a central non-peptide organic scaffold, such as a calix[4]arene, to which arelinked cyclic tetrapeptides; angiogenesis inhibiters; antitumor agents; solid tumors;anticarciogenic agents; restenosis
12/15/2009US7632646 Tuberculosis diagnostic test
12/15/2009US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc
12/15/2009US7632502 Immunoglobulin for diagnosis and prevention of yeast infections
12/15/2009CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof
12/10/2009WO2009148923A1 Hepatitis c virus inhibitors
12/10/2009US20090306036 Methods of screening agents, conjugates or conjugate moieties for transport by a pept2 transporter
12/10/2009US20090306030 Methods Of Inhibiting Osteoclast Activity
12/10/2009US20090305995 Agonists and antagonists of the somatostatin receptor
12/10/2009US20090304869 Peptides Having an Ace Inhibiting Effect
12/10/2009US20090304629 Macrocyclic hepatitis c serine protease inhibitors
12/10/2009US20090304626 Hepatitis C Virus Inhibitors
12/09/2009EP2130825A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof
12/09/2009EP2130548A2 Growth Hormone Releasing Peptides
12/09/2009EP1963357B1 Compounds for the inhibition of apoptosis
12/09/2009EP1020179B1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
12/09/2009CN101600730A Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
12/09/2009CN101600728A Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
12/09/2009CN101600428A Compounds and compositions as channel activating protease inhibitors
12/09/2009CN101597291A 2-aminoacyl tryptophyl-Beta-tetrahydric carboline-3-carboxylic acid carbobenzoxy as well as preparation method and application thereof
12/09/2009CN101597290A Beta-carboline-3-formyl tryptophyl amine acid carbamate as well as preparation method and application thereof
12/09/2009CN101597289A 2-tryptophanyl-Beta-tetrahydric carboline-3-formyol amino-acid benzyl ester and preparation method and application thereof
12/09/2009CN101597288A 2-aminoacyl-Beta-3-formyol tryptophan benzyl ester and preparation method and application thereof
12/08/2009US7629437 Fluorogenic materials and uses thereof
12/08/2009US7629319 inhibiting platelet aggregation; for treatment of thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, angiogenesis, cancer, and neurodegenerative disorders
12/08/2009US7629318 Immunosuppressant compounds, methods and uses related thereto
12/08/2009US7629317 Group of Gastric Antrum Mucosal Proteins that are gastrokines, designated AMP-18. AMP-18 genomic DNA, and cDNA molecules was sequenced for human and mouse, and the protein sequences are predicted from the nucleotide sequences; diagnostic and therapeutic agents for gastrointestinal tract
12/08/2009US7628989 Methods of inducing an immune response
12/08/2009CA2296742C Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
12/03/2009WO2009146347A1 Hepatitis c virus inhibitors
12/03/2009US20090299036 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
12/03/2009US20090299033 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules
12/03/2009US20090298919 Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/03/2009US20090298915 Topical drug delivery
12/03/2009US20090298781 Compounds for the inhibition of apoptosis
12/03/2009US20090298762 Conjugates of biologically active proteins having a modified in vivo half-life
12/03/2009US20090297689 Peptidylarginine deiminase and uses thereof in the production of citrullinated proteins and peptides
12/03/2009US20090297545 Immunomodulatory dairy peptides and uses thereof
12/02/2009EP2125878A1 Short bio-active peptides for cellular and immunological modulation
12/02/2009EP2125870A1 Inhibitors of hepatitis c ns3 protease
12/02/2009EP2125862A1 Methods for the synthesis of cyclic peptides
12/02/2009EP2125113A2 Tertiary amine substituted peptides useful as inhibitors of hcv replication
12/02/2009CN101595121A Pyrrolydine derivatives as IAP inhibitors
12/02/2009CN101591377A Aminoacyl-phenylalanyl-tryptophan or derivative, synthetic method and application thereof
12/02/2009CN101591376A Oligopeptide with thrombolysis activity, preparation method and application thereof
12/02/2009CN101591375A Compound with analgesic activity, preparation method and application thereof
12/02/2009CN101591348A Tetrahydrochysene carboline acyl aminoacid benzyl ester, preparation method and application thereof
12/02/2009CN101591335A N-(L-aminoacyl)-1, 2, 3, 4-tetrahydrochysene carboline acyl aminoacid benzyl ester, synthetic method and application thereof
12/01/2009US7626042 O-substituted hydroxyaryl derivatives
12/01/2009US7626023 Compounds for treating tumors
12/01/2009US7626002 Cytokine zalpha11 ligand antibodies
12/01/2009US7625870 Ala-Glu-Asp-Leu tetrapeptide of sequence 1; no side effects observed during long term administration; nontoxic; bronchitis, emphysema, asthma, COPD
12/01/2009US7625710 Methods for determining 2F1-binding compounds
11/2009
11/26/2009WO2009141687A1 New optically pure compounds for improved therapeutic efficiency
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 307